Fosamax (alendronate): Reviews and patient testimonials

Fosamax

'Fosamax' is indicated for the treatment of osteoporosis in post-menopausal women to prevent fractures.

'Fosamax' is indicated for the treatment of osteoporosis in men to prevent fractures.

'Fosamax' is indicated for the treatment of glucocorticoid-induced osteoporosis and prevention of bone loss in post-menopausal women considered at risk of developing the disease.

Risk factors often associated with the development of osteoporosis include thin body build, family history of osteoporosis, early menopause, moderately low bone mass and long-term glucocorticoid therapy, especially with high doses (≥15 mg/day).

Fosamax Once Weekly 70mg Tablets

FOSAMAX is indicated in adults for the treatment of postmenopausal osteoporosis. FOSAMAX reduces the risk of vertebral and hip fractures.

Route of administration: Oral
Molecule: alendronate